<DOC>
	<DOCNO>NCT02052635</DOCNO>
	<brief_summary>The purpose study determine ticagrelor effective clopidogrel rate onset degree platelet inhibition patient non-ST elevation acute coronary syndrome ( NSTE-ACS ) undergo ad hoc percutaneous coronary intervention ( PCI ) bivalirudin .</brief_summary>
	<brief_title>Ticagrelor v Clopidogrel Non-ST Elevation Acute Coronary Syndrome Patients Undergoing PCI With Bivalirudin .</brief_title>
	<detailed_description>Multi-center , open-label study compare onset platelet inhibition ticagrelor versus clopidogrel administer bivalirudin PCI background therapy aspirin patient NSTE-ACS .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<mesh_term>Hirudins</mesh_term>
	<mesh_term>Bivalirudin</mesh_term>
	<criteria>Hospitalised chest pain potential acute coronary syndrome . Onset recent cardiac ischemic symptom must occur within 7 day randomisation document cardiac ischemic symptom â‰¥ 10 min duration rest least 2 follow : ST segment change electrocardiogram ( ECG ) indicative ischemia , Positive biomarker evdience myocardial necrosis , risk factor : 60 yr age old , previous myocardial infarction coronary bypass surgery , multivessel coronary artery disease , diabetes mellitus , peripheral arterial disease , chronic renal disfunction . Females must either surgically sterile postmenopausal . Activated Clotting Time ( ACT ) &lt; /= 300 time study treatment Participation another clinical study investigational product last 30 day . Current acute complication percutaneous coronary intervention coronary bypass surgery . Any contraindication ticagrelor , clopidogrel bivalirudin . ST elevation myocardial infraction within 24 hour study entry . Any indication oral anticoagulation aspirin dose 75 100 milligram ( mg ) daily . Planned use omeprazole esomeprazole . Patients know bleed coagulation disorder ; patient require dialysis ; patient inability swallow medication . Patients know bleed diathesis coagulation disorder ; history intracranial bleed . Use Intravenous ( IV ) heparin le 2 hour procedure . Sustained uncontrolled high blood pressure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>130 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Percutaneous Coronary Intervention</keyword>
</DOC>